Officials of Greater Rochester Enterprise (GRE), an economic development organization dedicated to job creation in the Rochester region, next week will join a regional contingent of biotechnology companies and research institutions at the largest biotechnology trade show in the world, BIO 2004 Annual International Convention. The trade show, sponsored by the Biotechnology Industry Organization, will take place in San Francisco's Moscone Center June 6-9.
The Greater Rochester New York Booth 712 is part of the 21-booth New York State Pavilion at BIO 2004. Local biotechnology / life science companies — including Biophan Technologies, Integrated Nano-Technologies and Vaccinex — will join representatives from the University of Rochester Medical Center, GRE, Monroe County and the City of Rochester. This will be a unique opportunity for Rochester region universities, government, and the private sector to participate jointly in this show, which is expected to attract 17,000 attendees from 59 countries, including top biotech executives, investors, business, and university researchers from around the world.
"GRE is proud to participate in BIO 2004, one of the most important trade shows any of us will attend this year," said Michael Finney, President and CEO of Greater Rochester Enterprise. "The event attracts top decision-makers from leading biotechnology companies, and our participation is vital in raising their awareness of Greater Rochester and all that our region offers."
GRE and the Buffalo Niagara Enterprise (BNE) are partnering on the western New York focus area of the pavilion, highlighting research advancement and commercialization opportunities throughout this region of the state. GRE and BNE are also hosting a dinner prior to the show for a select group of 50 international business development targets.
GRE will debut its new 28-page brochure highlighting the Greater Rochester New York Region as an emerging biotechnology and life sciences industry hub and leader in discovery and innovation. The brochure provides extensive information on the region's university research efforts as well as detailed statistics on national and regional industry trends.
Business Facilities: The Location Advisor magazine recently ranked the Rochester metro area 26th in its "Top 40 Locations for Biotechnology." In the survey, Rochester's biotechnology sector ranked higher than those in Tampa, Florida, 27th; Portland, Oregon, 30th; and Austin, Texas, 37th. The New York City metro area placed 1st, while the Buffalo-Niagara Falls metro area ranked 40th.
The Rochester Region is home to more than 70 biotechnology and life sciences companies, employing more than 7,000 workers, ranging from the very small to the very large. The sector includes major manufacturers, cutting-edge research firms and emerging start-ups. Among them are university spin-off VirtualScopics, which counts Pfizer Inc. among its partners; Genencor International, which recently completed a $50 million manufacturing expansion here; and Celltech Pharmaceuticals, the U.S. headquarters of a leading European pharmaceutical firm. Celltech is in the process of merging with Belgian firm UCB Group to create what is expected to be one of the largest biopharmaceutical companies in the world.
The Rochester Region is also home to three top research institutions in the field — Rochester Institute of Technology, the University of Rochester, and Cornell Agriculture and Food Technology Park, providing companies with easy access to tomorrow's sharpest minds. RIT established the first biotechnology bachelor's program in the United States in 1983 and recently introduced bachelor's and master's degree programs in bioinformatics. University of Rochester's Aab Institute of Biomedical Sciences supports space and start-up capital for emerging biotech firms and is the centerpiece of a 10-year, $500 million strategic plan to expand the university's research programs.
Meanwhile, the Cornell Agriculture and Food Technology Park broke ground on its 72-acre campus this spring and is hard at work fostering agriculture, food and bio-based technologies in Rochester's Finger Lakes region.
"Biotechnology is an important sector in the Rochester regional economy, and has been for years," Finney said. "From eye care leader Bausch & Lomb, which marks its 150th anniversary in Rochester this year, to our newest biopharmaceutical firm, UCB Group, Rochester's biotechnology base is growing day-by-day."
Greater Rochester Enterprise (GRE) is a public-private partnership established to professionally market the Rochester metropolitan region as a competitive, high-profile place for business location and growth. GRE will collaborate with business, academia, not-for-profit organizations and government to ensure a unified approach to regional economic development efforts.